• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心率校正的收缩期射血时间:急性心力衰竭基于人群的参考值及差异预后效用

Heart rate-corrected systolic ejection time: population-based reference values and differential prognostic utility in acute heart failure.

作者信息

Morbach Caroline, Simon Isabelle, Danner Elisabeth, Gelbrich Götz, Stefenelli Ulrich, Sahiti Floran, Scholz Nina, Cejka Vladimir, Albert Judith, Ertl Georg, Angermann Christiane E, Güder Gülmisal, Frantz Stefan, Heuschmann Peter U, Maack Christoph, Störk Stefan

机构信息

Department Clinical Research and Epidemiology, Comprehensive Heart Failure Center, University Hospital Würzburg, Am Schwarzenberg 15, 97078 Würzburg, Germany.

Department Medicine I, University Hospital Würzburg, Oberdürrbacherstr. 6, 97080 Würzburg, Germany.

出版信息

Eur Heart J Imaging Methods Pract. 2023 Sep 12;1(2):qyad020. doi: 10.1093/ehjimp/qyad020. eCollection 2023 Sep.

DOI:10.1093/ehjimp/qyad020
PMID:39045077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11195710/
Abstract

AIMS

Systolic ejection time (SET) is discussed as a treatment target in patients with heart failure (HF) and a reduced left ventricular (LV) ejection fraction (EF). We derived reference values for SET correcting for its dependence on heart rate (SETc), and explored its prognostic utility in patients admitted with decompensated HF.

METHODS AND RESULTS

SETc was derived in 4836 participants of the population-based STAAB study (mean age 55 ± 12 years, 52% women). There, mean SETc was 328 ± 18 ms, increased with age (+4.7 ms per decade), was shorter in men than women (-14.9 ms), and correlated with arterial elastance ( = 0.30; all < 0.001). In 134 patients hospitalized with acute HF, SETc at admission was shorter when compared with the general population and differed between patients with HF with reduced EF (HFrEF; LVEF ≤40%; 269 ± 35 ms), HF with mildly reduced EF (HFmrEF; LVEF 41-49%; 294 ± 27 ms), and HF with preserved EF (HFpEF; LVEF ≥50%; 317 ± 35 ms; < 0.001). In proportional hazard regression, an in-hospital increase in SETc was associated with an age- and sex-adjusted hazard ratio of 0.38 (95% confidence interval 0.18-0.79) in patients with HFrEF, but a hazard ratio of 2.39 (95% confidence interval 1.24-4.64) in patients with HFpEF.

CONCLUSION

In the general population, SETc increased with age and an elevated afterload. SETc was mildly reduced in patients hospitalized with HFpEF, but markedly reduced in patients with HFrEF. In-hospital prolongation of SETc predicted a favourable outcome in HFrEF, but an adverse outcome in HFpEF. Our results support the concept of a U-shaped relationship between cardiac systolic function and risk, providing a rationale for a more individualized treatment approach in patients with HF.

摘要

目的

收缩期射血时间(SET)被探讨作为心力衰竭(HF)且左心室(LV)射血分数(EF)降低患者的治疗靶点。我们得出了校正心率依赖性后的SET参考值(SETc),并探讨了其在失代偿性HF住院患者中的预后价值。

方法与结果

在基于人群的STAAB研究的4836名参与者中得出SETc(平均年龄55±12岁,52%为女性)。在该研究中,平均SETc为328±18毫秒,随年龄增加(每十年增加4.7毫秒),男性比女性短(-14.9毫秒),且与动脉弹性相关(r=0.30;所有P<0.001)。在134例急性HF住院患者中,入院时的SETc与一般人群相比更短,且在射血分数降低的HF(HFrEF;LVEF≤40%;269±35毫秒)、射血分数轻度降低的HF(HFmrEF;LVEF 41-49%;294±27毫秒)和射血分数保留的HF(HFpEF;LVEF≥50%;317±35毫秒)患者之间存在差异(P<0.001)。在比例风险回归分析中,HFrEF患者住院期间SETc升高与年龄和性别校正后的风险比为0.38(95%置信区间0.18-0.79)相关,但HFpEF患者的风险比为2.39(95%置信区间1.24-4.64)。

结论

在一般人群中,SETc随年龄和后负荷升高而增加。HFpEF住院患者的SETc轻度降低,但HFrEF患者显著降低。住院期间SETc延长在HFrEF中预示良好结局,但在HFpEF中预示不良结局。我们的结果支持心脏收缩功能与风险之间呈U形关系的概念,为HF患者更个体化的治疗方法提供了理论依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8c/11195710/fa44e80295b0/qyad020f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8c/11195710/ccbf9316764f/qyad020_ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8c/11195710/36cc68b69da2/qyad020f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8c/11195710/c485ff0bb859/qyad020f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8c/11195710/fa44e80295b0/qyad020f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8c/11195710/ccbf9316764f/qyad020_ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8c/11195710/36cc68b69da2/qyad020f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8c/11195710/c485ff0bb859/qyad020f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8c/11195710/fa44e80295b0/qyad020f3.jpg

相似文献

1
Heart rate-corrected systolic ejection time: population-based reference values and differential prognostic utility in acute heart failure.心率校正的收缩期射血时间:急性心力衰竭基于人群的参考值及差异预后效用
Eur Heart J Imaging Methods Pract. 2023 Sep 12;1(2):qyad020. doi: 10.1093/ehjimp/qyad020. eCollection 2023 Sep.
2
Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.在中国 4880 例队列中,射血分数保留、轻度降低和降低的心衰患者的 5 年死亡率。
ESC Heart Fail. 2022 Aug;9(4):2336-2347. doi: 10.1002/ehf2.13921. Epub 2022 Apr 18.
3
Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.日本住院心力衰竭患者射血分数保留、中间范围和降低的临床特征。
ESC Heart Fail. 2019 Jun;6(3):475-486. doi: 10.1002/ehf2.12418. Epub 2019 Mar 3.
4
Predictors and prognostic implications of left ventricular ejection fraction trajectory improvement in the spectrum of heart failure with reduced and mildly reduced ejection fraction.射血分数降低和轻度降低的心力衰竭谱中左心室射血分数轨迹改善的预测因素及其预后意义。
J Cardiol. 2024 Apr;83(4):250-257. doi: 10.1016/j.jjcc.2023.09.012. Epub 2023 Oct 5.
5
[Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].[中国实际临床实践中住院心力衰竭患者的当代流行病学与治疗]
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Nov 24;47(11):865-874. doi: 10.3760/cma.j.issn.0253-3758.2019.11.004.
6
Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.左心室射血分数中等范围的急性心力衰竭:临床特征、住院治疗及短期预后
Clin Res Cardiol. 2017 May;106(5):359-368. doi: 10.1007/s00392-016-1063-0. Epub 2016 Dec 20.
7
Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.心力衰竭与中等射血分数:射血分数恢复对运动耐量和预后的影响
Circ Heart Fail. 2016 Apr;9(4):e002826. doi: 10.1161/CIRCHEARTFAILURE.115.002826.
8
Distinctive left ventricular-arterial and right ventricular-pulmonary arterial coupling observed in patients with heart failure and a higher left ventricular ejection fraction range.在心力衰竭且左心室射血分数范围较高的患者中观察到独特的左心室-动脉和右心室-肺动脉耦合。
Eur Heart J Cardiovasc Imaging. 2024 May 31;25(6):774-781. doi: 10.1093/ehjci/jeae033.
9
Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction.地高辛对心力衰竭伴左心室射血分数中间值(边缘值)患者的影响。
Eur J Heart Fail. 2018 Jul;20(7):1139-1145. doi: 10.1002/ejhf.1160. Epub 2018 Mar 1.
10
Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.用多非利特治疗射血分数保留和轻度降低的心衰伴发的心房颤动:ATHENA 试验的事后分析。
Eur J Heart Fail. 2022 Jun;24(6):1094-1101. doi: 10.1002/ejhf.2487. Epub 2022 Apr 10.

引用本文的文献

1
Investigating the Anrep Effect in Hypertrophic Obstructive Cardiomyopathy With Invasive Pressure-Volume Analysis.通过有创压力-容积分析研究肥厚性梗阻性心肌病中的安雷普效应。
JACC Adv. 2025 Apr 18;4(5):101728. doi: 10.1016/j.jacadv.2025.101728.
2
Regional mechanical dyssynchrony and shortened systole are present in people with Takotsubo syndrome.应激性心肌病患者存在局部机械性不同步和收缩期缩短。
Commun Med (Lond). 2024 Nov 1;4(1):223. doi: 10.1038/s43856-024-00641-5.

本文引用的文献

1
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial.钠-葡萄糖协同转运蛋白 2 抑制剂恩格列净治疗急性心力衰竭住院患者的多中心随机试验。
Nat Med. 2022 Mar;28(3):568-574. doi: 10.1038/s41591-021-01659-1. Epub 2022 Feb 28.
2
Phenotyping heart failure using model-based analysis and physiology-informed machine learning.基于模型分析和生理学启发的机器学习对心力衰竭进行表型分析。
J Physiol. 2021 Nov;599(22):4991-5013. doi: 10.1113/JP281845. Epub 2021 Oct 18.
3
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
4
Prevalence and determinants of the precursor stages of heart failure: results from the population-based STAAB cohort study.心力衰竭前期阶段的患病率及其决定因素:基于人群的 STAAB 队列研究结果。
Eur J Prev Cardiol. 2021 Aug 9;28(9):924-934. doi: 10.1177/2047487320922636. Epub 2020 May 6.
5
Effect of Ejection Fraction on Clinical Outcomes in Patients Treated With Omecamtiv Mecarbil in GALACTIC-HF.射血分数对 GALACTIC-HF 中接受 Omecamtiv Mecarbil 治疗的患者临床结局的影响。
J Am Coll Cardiol. 2021 Jul 13;78(2):97-108. doi: 10.1016/j.jacc.2021.04.065. Epub 2021 May 17.
6
The significance of left ventricular ejection time in heart failure with reduced ejection fraction.左心室射血时间在射血分数降低型心力衰竭中的意义。
Eur J Heart Fail. 2021 Apr;23(4):541-551. doi: 10.1002/ejhf.2125. Epub 2021 Mar 23.
7
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.肌球蛋白激活治疗收缩性心力衰竭的奥马曲珠单抗
N Engl J Med. 2021 Jan 14;384(2):105-116. doi: 10.1056/NEJMoa2025797. Epub 2020 Nov 13.
8
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.马卡丹特治疗有症状梗阻性肥厚型心肌病(EXPLORER-HCM)的随机、双盲、安慰剂对照、3 期临床试验
Lancet. 2020 Sep 12;396(10253):759-769. doi: 10.1016/S0140-6736(20)31792-X. Epub 2020 Aug 29.
9
Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trial.新型肌球蛋白激活剂丹卡莫司他治疗射血分数降低型心力衰竭的效果:来自 2a 期临床试验的实验数据和临床结果。
Eur J Heart Fail. 2020 Sep;22(9):1649-1658. doi: 10.1002/ejhf.1933. Epub 2020 Jul 10.
10
CaMKII activity contributes to homeometric autoregulation of the heart: A novel mechanism for the Anrep effect.CaMKII 活性有助于心脏等容自身调节:安纳普效应的新机制。
J Physiol. 2020 Aug;598(15):3129-3153. doi: 10.1113/JP279607. Epub 2020 Jun 14.